Product Portfolio



Our portfolio includes more than 25 specialized products aimed at providing innovative treatments for unmet medical needs worldwide.

The list below includes our products marketed in the United States. Many of these, as well as other Sanofi Genzyme products, are also approved and marketed in other parts of the world.

Contact Sanofi Genzyme in your region if you are outside the U.S. and want to learn about products available in your area.

Alprolix logo

Alprolix® [Coagulation Factor IX (Recombinant), Fc Fusion Protein]

Cerezyme logo

Cerezyme® (imiglucerase for injection)

Clolar logo

Clolar® (clofarabine injection)

Eloctate logo

Elocatate® [Antihemophilic Factor (Recombinant), Fc Fusion Protein]

Mozobil logo

MOZOBIL® (plerixafor) injection

Taxotere logo

TAXOTERE® (docetaxel) injection concentrate

Thymoglobulin logo

Thymoglobulin® [Anti-thymocyte Globulin (Rabbit)]

Thyrogen logo

Thyrogen® (thyrotropin alfa for injection)

Zaltrap logo

ZALTRAP® (ziv-aflibercept) injection for intravenous infusion

Scientist in the lab

What’s in the pipeline?

New product candidates and advances in technology are featured in our product pipeline, which highlights our key research from early stage programs to phase 3 clinical trials.